News
Transgene signs a Joint Venture agreement with Atral Cipan of Portugal involving...
4th Jan 2013
Transgene signs a Joint Venture agreement with Atral Cipan of Portugal involving the technology transfer of Tacrolimus by Transgene, followed by the manufacturing and global marketing in regulated and unregulated markets by Cipan.
 


Transgene Biotek becomes the world’s first company to create and launch...
23rd Feb 2013
Transgene Biotek becomes the world’s first company to create and launch 50% algal DHA oil, and 20% algal DHA powder. Sales of TrabiDHATM in both oil and powder forms continue to grow as market demand outstrips supply
 


Transgene Biotek finds partner to manufacture DHA in facility geared towards...
2nd Sep 2013
Transgene Biotek finds partner to manufacture DHA in facility geared towards sales in regulated markets. Commercial operations from this new unit are expected to commence during the last quarter of the current financial year 2013-14.
 


TBL1002 OI (Oral delivery of Insulin) continues to demonstrate exciting results...
TBL1002 OI (Oral delivery of Insulin) continues to demonstrate exciting results both in the laboratory and in trials held at external facilities. Expect more news on this soon
 
 
© 2011. TRANSGENE BIOTEK LIMITED., All Rights Reserved. Designed by BitraNet